ameli.fr - Références des publications scientifiques

Accès rapide

Aller à la navigation principale Aller à la recherche Aller à l'aide Aller au plan du site Aller au contenu Aller à la pagination
L'Assurance maladie (logo): retour accueil portail

ameli.fr
l'assurance maladie en ligne

Vous êtes ici :

Accueil.Statistiques et publications.Études en santé publique.Références des publications scientifiques

Références des publications scientifiques

Version imprimableEnvoyer cette page à un ami
Dossier mis à jour le 12 avril 2018
Cette rubrique recense les publications scientifiques, dans des revues à comité de lecture, de travaux réalisés par l’Assurance Maladie ainsi que des travaux réalisés par des équipes institutionnelles ou de recherche en partenariat avec la Cnam.
Passer le sommaire

Au sommaire du dossier

Références des publications de 2017

1. Atramont A, Bonnet-Zamponi D, Bourdel-Marchasson I, Tangre I, Fagot-Campagna A, Tuppin P. Health status and drug use 1 year before and 1 year after skilled nursing home admission during the first quarter of 2013 in France: a study based on the French National Health Insurance Information System. Eur J Clin Pharmacol. 2018 Jan;74(1):109-118.

2. Atramont A, Bourdel-Marchasson I, Bonnet-Zamponi D, Tangre I, Fagot-Campagna A, Tuppin P. Impact of nursing home admission on health care use and disease status elderly dependent people one year before and one year after skilled nursing home admission based on 2012-2013 SNIIRAM data. BMC Health Serv Res. 2017 Sep 18;17(1):667.

3. Atramont A, Rigault A, Chevalier S, Leblanc G, Fagot-Campagna A, Tuppin P Characteristics, diseases and mortality of people admitted to nursing homes for dependent seniors during the first quarter of 2013 in France. Rev Epidemiol Sante Publique. 2017 Jun;65(3):221-230.

4. Billionnet C, Alla F, Bérigaud É, Pariente A, Maura G. Identifying atrial fibrillation in outpatients initiating oral anticoagulants based on medico-administrative data: results from the French national healthcare databases. Pharmacoepidemiol Drug Saf. 2017 May;26(5):535-543.

5. Billionnet C, Mitanchez D, Weill A, Nizard J, Alla F, Hartemann A, Jacqueminet S. Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012. Diabetologia. 2017 Apr;60(4):636-644.

6. de Lagasnerie G, Aguadé AS, Denis P, Fagot-Campagna A, Gastaldi-Menager C. The economic burden of diabetes to French national health insurance: a new cost-of-illness method based on a combined medicalized and incremental approach. Eur J Health Econ. 2018 Mar;19(2):189-201.

7. Delannoy A, Rudant J, Chaignot C, Bolgert F, Mikaeloff Y, Weill A. Guillain-Barré syndrome in France: a nationwide epidemiological analysis based on hospital discharge data (2008-2013). J Peripher Nerv Syst. 2017 Mar;22(1):51-58.

8. * Fonteneau L, Le Meur N, Cohen-Akenine A, Pessel C, Brouard C, Delon F, Desjeux G, Durand J, Kirchgesner J, Lapidus N, Lemaitre M, Tala S, Thiébaut A, Watier L, Rudant J, Guillon-Grammatico L. [The use of administrative health databases in infectious disease epidemiology and public health]. Rev Epidemiol Sante Publique. 2017 Oct;65 Suppl 4:S174-S182.

9. Foulon S, Maura G, Dalichampt M, Alla F, Debouverie M, Moreau T, Weill A. Prevalence and mortality of patients with multiple sclerosis in France in 2012: a study based on French health insurance data. J Neurol. 2017 Jun;264(6):1185-1192.

10. * Gallini A, Moisan F, Maura G, Carcaillon-Bentata L, Leray E, Haesebaert J, Bruandet A, Moutengou E, Luciano L, Weill A, Marin B, Gardette V. I Identification of neurodegenerative diseases in administrative databases in France: A systematic review of the literature. Rev Epidemiol Sante Publique. 2017 Oct;65 Suppl 4:S183-S197.

11. * Le Pogam MA, Quantin C, Reich O, Tuppin P, Fagot-Campagna A, Paccaud F, Peytremann-Bridevaux I, Burnand B. Geriatric Patient Safety Indicators Based on Linked Administrative Health Data to Assess Anticoagulant-Related Thromboembolic and Hemorrhagic Adverse Events in Older Inpatients: A Study Proposal. JMIR Res Protoc. 2017 May 11;6(5):e82.

12. Lefeuvre D, Rudant J, Foulon S, Alla F, Weill A. Healthcare expenditure of multiple sclerosis patients in 2013: a nationwide study based on French health administrative database. Mult Scler J Exp Transl Clin. 2017 Sep 13;3(3):2055217317730421.

13. Mathonnet M, Cuerq A, Tresallet C, Thalabard JC, Fery-Lemonnier E, Russ G, Leenhardt L, Bigorgne C, Tuppin P, Millat B, Fagot-Campagna A. What is the care pathway of patients who undergo thyroid surgery in France and its potential pitfalls? A national cohort. BMJ Open. 2017 Apr 7;7(4):e013589.

14. Maura G, Billionnet C, Alla F, Gagne JJ, Pariente A. Comparison of treatment persistence with dabigatran or rivaroxaban versus vitamin K antagonist oral anticoagulants in atrial fibrillation patients: a competing risk analysis in the French nationwide healthcare databases. Pharmacotherapy. 2018 Jan;38(1):6-18.

15. Maura G, Chaignot C, Weill A, Alla F, Heard I. Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study. Eur J Cancer Prev. 2017 May 10.

16. Maura G, Chaignot C, Weill A, Alla F, Heard I. Dépistage du cancer du col de l’utérus et actes associés chez les femmes de moins de 25 ans entre 2007 et 2013 en France : une étude sur les bases de données médico-administratives françaises. Bull Epidémiol Hebd. 2017;(2-3): 32-8.

17. Maura G, Pariente A, Alla F, Billionnet C. Adherence with direct oral anticoagulants in nonvalvular atrial fibrillation new users and associated factors: a French nationwide cohort study. Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1367-1377.

18. Miranda S, Chaignot C, Collin C, Dray-Spira R, Weill A, Zureik M. Human papillomavirus vaccination and risk of autoimmune diseases: A large cohort study of over 2 million young girls in France. Vaccine. 2017 Aug 24;35(36):4761-4768.

19. * Poidvin A, Weill A, Ecosse E, Coste J, Carel JC. Risk of diabetes treated in early adulthood following growth hormone treatment for short stature in childhood. J Clin Endocrinol Metab. 2017 Apr 1;102(4):1291-1298.

20. * Poujois A, Woimant F, Samson S, Chaine P, Girardot-Tinant N, Tuppin P. Characteristics and prevalence of Wilson's disease: A 2013 observational population-based study in France. Clin Res Hepatol Gastroenterol. 2018 Feb;42(1):57-63.

21. Poulalhon C, Rotelli-Bihet L, Raso C, Aubry R, Fagot-Campagna A, Tuppin P. Deaths in France: Characteristics, place of death, hospitalisations and use of palliative care during the year before death. Rev Epidemiol Sante Publique. 2018 Feb;66(1):33-42.

22. Thereaux J, Lesuffleur T, Czernichow S, Basdevant A, Msika S, Nocca D, Millat B, Fagot-Campagna A. Do sleeve gastrectomy and gastric bypass influence treatment with proton pump inhibitors 4 years after surgery? A nationwide cohort. Surg Obes Relat Dis. 2017 Jun;13(6):951-959.

23. Thereaux J, Lesuffleur T, Czernichow S, Basdevant A, Msika S, Nocca D, Millat B, Fagot-Campagna A. To What Extent Does Posthospital Discharge Chemoprophylaxis Prevent Venous Thromboembolism After Bariatric Surgery?: Results From a Nationwide Cohort of More Than 110,000 Patients. Ann Surg. 2018 Apr;267(4):727-733.

24. Thereaux J, Lesuffleur T, Païta M, Czernichow S, Basdevant A, Msika S, Millat B, Fagot-Campagna A. Long-term follow-up after bariatric surgery in a national cohort. Br J Surg. 2017 Sep;104(10):1362-1371.

25. Tubiana S, Blotière PO, Hoen B, Lesclous P, Millot S, Rudant J, Weill A, Coste J, Alla F, Duval X. Dental procedures, antibiotic prophylaxis, and endocarditis among people with prosthetic heart valves: nationwide population based cohort and a case crossover study. BMJ. 2017 Sep 7;358:j3776.

26. Tuppin P, Cuerq A, Torre S, Couchoud C, Fagot-Campagna A. Management of patients with end-stage renal disease prior to initiation of renal replacement therapy in 2013 in France. Nephrol Ther. 2017 Apr;13(2):76-86.

27. Tuppin P, Cuerq A, Torre S, Couchoud C, Fagot-Campagna A. Management of diabetes patients during the year prior to initiation of dialysis in France. Diabetes Metab. 2017 Jun;43(3):265-268.

28. Tuppin P, Leboucher C, Peyre-Lanquar G, Lamy PJ, Gabach P, Rébillard X. Rates of total and free PSA prescriptions in France (2012-2014). Presse Med. 2017 Oct;46(10):e237-e247.

29. Tuppin P, Pestel L, Samson S, Cuerq A, Rivière S, Tala S, Denis P, Drouin J, Gissot C, Gastaldi-Ménager C, Fagot-Campagna A. The human and economic burden of cancer in France in 2014, based on the Sniiram national database. Bull Cancer. 2017 Jun;104(6):524-537.

30. Tuppin P, Rudant J, Constantinou P, Gastaldi-Ménager C, Rachas A, de Roquefeuil L, Maura G, Caillol H, Tajahmady A, Coste J, Gissot C, Weill A, Fagot-Campagna A. Value of a national administrative database to guide public decisions: From the système national d'information interrégimes de l'Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France. Rev Epidemiol Sante Publique. 2017 Oct;65 Suppl 4:S149-S167.

 

* Ces études ont été réalisées par des équipes extérieures à l’Assurance Maladie, avec l’appui et la participation de la Cnam.

Documents à télécharger

Références des publications de 2017

Publications scientifiques dans des revues à comité de lecture

Rubriques annexes